Open AccessAnti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience
Author(s) -
Al jarroudi Ouissam,
Chaabouni Hamed,
Ulusakarya Ayhan,
Almohamad Wathek,
Gumus Yusuf,
Goldschmidt Emma,
Afqir Said,
Morère Jeanfrancois
Publication year - 2021
Publication title -
clinical case reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3970
Subject(s) - medicine , hepatocellular carcinoma , nivolumab , rescue therapy , oncology , intensive care medicine , cancer , immunotherapy
Nivolumab is an effective and safe treatment in HCC.